Departamento de Dermatologia - FM/MDT
Collections in this community
Recent Submissions
-
Are dogs not susceptible to retroviral infections?
ANIMAL DISEASES, v.3, n.1, article ID 31, p, 2023
Retroviruses have been proven to cause infections and diseases in a series of mammalian hosts but not in dogs. Then, this letter discussed the dog susceptibility to retrovirus infection, encompassing arguments to understand why dogs may have not been infected by retroviruses thus far. The potenti...
-
Autoimmune diseases related to post-SARS-CoV-2 vaccination: A rheumatology perspective
VACUNAS, v.24, n.4, p.400-401, 2023
-
A LARGE LANGUAGE MODEL ARTIFICIAL INTELLIGENCE FOR PATIENT QUERIES IN ATOPIC DERMATITIS
ACTA DERMATO-VENEREOLOGICA, v.103, p.21-21, 2023
-
Impact of climate change on atopic dermatitis: A systematic search and review by the International Eczema Council
JOURNAL OF INVESTIGATIVE DERMATOLOGY, v.143, n.9, p.B12-B12, 2023
-
Chromoblastomycosis: New Perspective on Adjuvant Treatment with Acitretin
DISEASES, v.11, n.4, article ID 162, 8p, 2023
Chromoblastomycosis (CBM) is a neglected human disease, caused by different species of pigmented dematiaceous fungi that cause granulomatous and suppurative dermatosis. This infection is difficult to treat and there are limited therapeutic options, including terbinafine, itraconazole, and tiocona...
-
New Immunological Markers in Chromoblastomycosis-The Importance of PD-1 and PD-L1 Molecules in Human Infection
JOURNAL OF FUNGI, v.9, n.12, article ID 1172, 15p, 2023
The pathogenesis of chromoblastomycosis (CBM) is associated with Th2 and/or T regulatory immune responses, while resistance is associated with a Th1 response. However, even in the presence of IFN-gamma, fungi persist in the lesions, and the reason for this persistence is unknown. To clarify the f...
-
Imiquimod chemoprophylaxis for field cancerization in xeroderma pigmentosum patients-A prospective study
AUSTRALASIAN JOURNAL OF DERMATOLOGY, v.64, n.3, p.435-438, 2023
-
Aryl-hydrocarbon receptor agonist: A novel topical therapeutic approach for inflammatory skin diseases
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, v.37, n.6, p.1093-1094, 2023
-
Can COVID-19 impact the natural history of paracoccidioidomycosis? Insights from an atypical chronic form of the mycosis
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, v.65, article ID e57, 6p, 2023
Paracoccidioidomycosis (PCM) is a systemic fungal infection caused by Paracoccidioides spp. It can occur as an acute/subacute form (A/SAF), a chronic form (CF) and rarely as a mixed form combining the features of the two aforementioned forms in an immunocompromised patient. Here, we report a 56-y...
-
A common variant close to the ""tripwire"" linker region of <i>NLRP1</i> contributes to severe COVID-19
INFLAMMATION RESEARCH, v.72, n.10-11, p.1933-1940, 2023
Objective and design The heterogeneity of response to SARS-CoV-2 infection is directly linked to the individual genetic background. Genetic variants of inflammasome-related genes have been pointed as risk factors for several inflammatory sterile and infectious disease. In the group of inflammasom...
Discover
- 600 article
- 132 conferenceObject
- 65 bookPart
- 3 book
- 439 original article
- 132 meeting abstract
- 67 review
- 65 book chapter
- 58 letter
- next >
- 544 restrictedAccess
- 256 openAccess